---
schema_version: "secwatch.filing_event.v1"
accession: "0000021076-22-000021"
form_type: "8-K"
ticker: "CLX"
cik: "0000021076"
company_name: "CLOROX CO /DE/"
filed_at: "2022-08-03T23:59:59+00:00"
generated_at: "2026-06-24T05:28:52.462871+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Clorox Q4 net sales flat, gross margin compressed; announces streamlined operating model; FY23 cautious

## Summary
- Q4 net sales flat at $1.8B; organic sales +1%; diluted EPS $0.81 (+4% YoY); adjusted EPS $0.93 (-2%).
- FY22 net sales $7.1B (-3% YoY); gross margin 35.8% vs 43.6% prior year; free cash flow $535M vs $945M.
- Health & Wellness segment volume -18% in Q4; net sales -5% despite pricing benefits; three-year avg growth +3%.
- Announces streamlined operating model to create faster, simpler company, move decision-making closer to consumers.
- FY23 outlook: environment remains difficult with inflation and portfolio normalization; expects margin rebuilding.

## SEC filing metadata
- accession: 0000021076-22-000021
- form_type: 8-K
- ticker: CLX
- cik: 0000021076
- company_name: CLOROX CO /DE/
- filed_at: 2022-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/21076/000002107622000021/0000021076-22-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/21076/000002107622000021/clx-20220803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000021076-22-000021
- JSON: https://secwatch.observer/filing/0000021076-22-000021.json
- Plain text: https://secwatch.observer/filing/0000021076-22-000021.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.